Nitric oxide produced via neuronal NOS may impair vasodilatation in septic rat skeletal muscle. Am J Physiol Heart Circ Physiol 278: H1480-H1489, 2000.-Impaired vascular responsiveness in sepsis may lead to maldistribution of blood flow in organs. We hypothesized that increased production of nitric oxide (NO) via inducible nitric oxide synthase (iNOS) mediates the impaired dilation to ACh in sepsis. Using a 24-h cecal ligation and perforation (CLP) model of sepsis, we measured changes in arteriolar diameter and in red blood cell velocity (V RBC ) in a capillary fed by the arteriole, following application of ACh to terminal arterioles of rat hindlimb muscle. Sepsis attenuated both ACh-stimulated dilation and V RBC increase. In control rats, arteriolar pretreatment with the NO donors S-nitroso-N-acetylpenicillamine or sodium nitroprusside reduced diameter and V RBC responses to a level that mimicked sepsis. In septic rats, arteriolar pretreatment with the ''selective'' iNOS blockers aminoguanidine (AG) or S-methylisothiourea sulfate (SMT) restored the responses to the control level. The putative neuronal NOS (nNOS) inhibitor 7-nitroindazole also restored the response toward control. At 24-h post-CLP, muscles showed no reduction of endothelial NOS (eNOS), elevation of nNOS, and, surprisingly, no induction of iNOS protein; calcium-dependent constitutive NOS (eNOSϩnNOS) enzyme activity was increased whereas calcium-independent iNOS activity was negligible. We conclude that 1) AG and SMT inhibit nNOS activity in septic skeletal muscle, 2) NO could impair vasodilative responses in control and septic rats, and 3) the source of increased endogenous NO in septic muscle is likely upregulated nNOS rather than iNOS. Thus agents released from the blood vessel milieu (e.g., NO produced by skeletal muscle nNOS) could affect vascular responsiveness.
arteriole; acetylcholine; nitric oxide synthase NITRIC OXIDE (NO) is a potent vasodilator, synthesized by a family of isoenzymes, nitric oxide synthases (NOS; 32). This family is subdivided into two categories: one of constitutively expressed enzymes (cNOS) that produce low (nmol) levels of NO and require an increase in intracellular calcium to stimulate activity; and another that is a high-output, inducible enzyme [inducible nitric oxide synthase (iNOS), type II NOS] for which activity is independent of a calcium trigger. The high levels of NO produced via iNOS subserve pathophysiological events requiring macrophage cytotoxic activity (23) . The cNOS enzymes are subdivided into two distinct gene products, which produce an endothelial (eNOS, type III) and a neuronal (nNOS, type I) form, based on the cell types in which these isozymes were first described (9) . Furthermore, a splice-variant of the nNOS gene exists, which is expressed primarily within skeletal muscle (µNOS; 37). The constitutive isozymes produce NO to subserve autonomic and central nervous control (3, 5) , to subserve vascular tone control (16) , and to participate in pathophysiology (8) .
Sepsis is often defined as a systemic inflammatory response to a local infectious or noninfectious insult. In terms of cardiovascular effects, the reduced responsiveness to vasoconstrictive (14) and vasodilative stimuli (1, 25, 34, 49) is one of the key features of sepsis. Impaired vascular response may lead to inappropriate distribution of blood flow to vital organs (19) , maldistribution of flow within an organ (18) , abnormal microvascular control of tissue oxygenation (36) , and eventual multiple organ dysfunction (18) . It has been shown that sepsis-induced production of NO by iNOS could be responsible for the vasoconstriction and vasodilation deficits (1, 14, 25, 38) . In terms of the vasodilation deficit, data from our laboratory (46) underscored the significant role of NO in that the attenuation of arteriolar dilation after local application of ACh in septic skeletal muscle was eliminated by the ''selective'' iNOS blocker aminoguanidine (AG).
The mechanism of reduced vascular sensitivity to ACh (or to other endothelium-dependent stimuli) in sepsis is not clear. Although the intracellular response to ACh in the endothelium can occur along several pathways, it is likely that sepsis affects the endotheliumderived relaxing factor (EDRF)/NO pathway. Previous reports suggest that downregulation (22, 24, 52, 53) and/or functional inhibition (negative feedback) of eNOS, mediated by the continuous production of NO during sepsis (4, 6, 26, 38) , could possibly account for the reduced sensitivity. Our recent study (46) supported the latter possibility, because the restoration of the vasodilation to ACh occurred within 5-7 min after AG application, not allowing sufficient time for de novo synthesis of eNOS.
The role of NO in functional inhibition of agonistinduced dilation in sepsis is poorly understood. On the basis of our recent work (38, 46) , the objective of the The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ''advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
present study was to determine the effect of an increased level of NO, produced either exogenously or via iNOS, on arteriolar dilation to ACh in septic skeletal muscle. To this end, we have examined the NOmediated attenuation of vasodilation to ACh using both NO donors and ''selective'' inhibitors of iNOS.
MATERIALS AND METHODS

Animal Preparation
The experimental protocol was approved by the University Council on Animal Care at the University of Western Ontario. Male Sprague-Dawley rats (300-350 g) were acclimatized for 1 wk and then divided into control and septic groups. Rats in the septic group were subjected to the same model of sepsis as described previously (46) . We defined sepsis as the outcome of cecal ligation and perforation (CLP), laparotomy, line insertion, and resuscitation with a fluid mixture, to mimic the clinical situation of sepsis involving a surgical intervention (e.g., laparotomy) and fluid resuscitation via an inserted line. Consistent with the previous study (46) , control rats did not undergo surgery or fluid resuscitation.
Briefly, rats in the septic group were given a mixture of halothane (1-2%) and oxygen (remainder) throughout the CLP procedure. A right carotid artery catheter (PE-50) was tunnelled through a posterior neck incision and advanced to the ascending aorta to permit infusion of fluids, withdrawal of blood samples [for blood gases, lactate, and NO metabolite (nitrate and nitrite) determinations], and measurement of blood pressure. Subsequently, the carotid catheter was attached to a swivel harness to allow free movement of the rat in its cage. A midline laparotomy was performed, and the cecum was isolated and ligated distal to the ileocecal valve to maintain bowel integrity. The cecum was punctured twice with an 18-gauge needle and returned to the peritoneal cavity. Incisions were sutured, and the carotid line was infused with a mixture of saline (10 ml · kg Ϫ1 ·h Ϫ1 ), fentanyl (analgesic; 10 µg · kg Ϫ1 ·h Ϫ1 ), and heparin (0.5 U/h) via an infusion pump. Rats were allowed free access to food and water after recovering from the halothane anaesthesia. Twenty-four hours later, septic rats were prepared for intravital microscopy.
Intravital Microscopy
Both septic and control rats were anesthetized through an intraperitoneal injection of pentobarbital sodium (65 mg/kg; Somnotol, MTC Pharmaceuticals) with subsequent injections (32 mg/kg) every 30-60 min to maintain the anesthetized state. Rats were placed on the stage of an intravital microscope (Leitz, ELR) equipped with a heating pad maintained at 37°C (K20C, American Medical System) and a heating lamp. The carotid artery of control rats was cannulated at this time as described above. Tracheostomy was performed on rats from both groups to allow for ventilation with 70% N 2 -30% O 2 (tidal volume 2.5 ml at 70 strokes/min). Exposure of the extensor digitorum longus (EDL) muscle was carried out as described by Tyml and Budreau (44) . A plastic coverslip (18 ϫ 18 mm) with a 3-mm diameter hole surrounded by a silicone ring was placed on the EDL muscle and filled with an ϳ2-mm layer of degassed heavy mineral oil. This allowed for micropipette access to the microcirculation at the muscle surface and prevented drying of the surface. The preparation was epi-illuminated with a Schott SL 1500 fiberoptic light source. The microcirculation was allowed to stabilize for 30 min before experiments were performed.
Local Application of Drugs
Minute amounts of drugs were delivered to arterioles at the muscle surface via glass micropipettes and a pressurized air source (Picospritzer II, General Valve). After a pipette was mounted on a micromanipulator and lowered into the oil layer, an air pulse (30 psi; 10-20 ms) produced a small spherical droplet of drug (ϳ50-60 µm diameter) at the pipette tip. The droplet was then lowered onto an arteriole using the technique of Dietrich (7) . Pipettes (tips Ͻ3 µm diameter) were filled with one of the following drugs: 10 mM ACh, 5 mM sodium nitroprusside (SNP), 5 mM S-nitroso-Nacetylpenicillamine (SNAP), 15 mM N -nitro-L-arginine (L-NNA), 10 mM AG, 5 µM S-methylisothiourea sulfate (SMT), 100 µM 7-nitroindazole (7-NI; all from Sigma), and 10 µM 5Ј-N-ethylcarboxamidoadenosine (NECA, adenosine analog; RBI). ACh and L-NNA were dissolved in a phosphate-buffered solution (PBS, pH 6.8; composition in mM: 138.9 NaCl, 2.25 KCl, 2.25 KH 2 PO 4 , and 1.4 Na 2 HPO 4 ). SNP, SNAP, AG, and SMT were dissolved in 0.9% saline solution. NECA was dissolved in Dulbecco's PBS (pH 7.4; GIBCO). Drugs in the pipette were estimated to be diluted ϳ100-fold before reaching the arteriolar wall (28) . The present pipette concentrations were based on pipette concentrations found effective in our previous studies (28, 46) and on preliminary concentrationresponse investigations carried out in our laboratory.
Evaluation of Microvascular Response
The epi-illuminated EDL muscle preparation is not optimal for arteriolar diameter measurement because the microscopic image of the vessel wall cannot be seen as sharply as in a transilluminated preparation. For this reason, the majority of responses to arteriolar stimuli were evaluated in terms of changes in red blood cell velocity (V RBC ) in a daughter capillary fed by the stimulated arteriole. The acute arteriolar diameter change is almost entirely responsible for the ensuing acute capillary V RBC change (28); furthermore, V RBC change is a more sensitive index of the response than the diameter change (40) . Nevertheless, arteriolar diameters were measured where possible for confirmatory purposes. Capillary blood flow was visualized at the final magnification of ϫ240 using the Leitz microscope [ϫ10/0.22 numerical aperature (NA) objective and ϫ6.3 eyepiece], connected to a closed-circuit television system (Panasonic MV5410 monitor, MTI camera, Mitsubishi U82 sVHS videotape recorder). V RBC was measured by the video flying spot technique (45) . Arteriolar diameter was measured from the video screen at the final magnification of ϫ1,220 (ϫ32/0.40 NA objective and ϫ10 eyepiece) at a resolution of Ϯ 1 µm.
Arterioles selected arbitrarily were stimulated 100-200 µm upstream from the most distal capillary fed by the arteriole. An average of six arterioles were stimulated in one EDL muscle per rat. Diameters were measured at the site of stimulation along a 100-µm segment before and after the stimulation. Measurements along the segment were averaged to obtain control diameters (D con ) and peak poststimulus diameters (D peak ). The percent diameter response was calculated as ⌬D (%) ϭ 100% ϫ (D peak Ϫ D con )/D con . V RBC response was measured in a capillary fed by the stimulated arteriole. We required that the 2-min average baseline V RBC (V RBC con ) in this capillary was in the range of ϳ100-200 µm/s. Our preliminary experiments in control rats demonstrated that the percent V RBC increase caused by the feeding arteriole stimulation with ACh was inversely related to V RBC con (data not shown). The selection of capillary with velocity within the range was required to ensure that a possible treatmentinduced attenuation of the V RBC response to ACh was not due to the baseline V RBC effect. In general, V RBC response was calculated as ⌬V RBC (%) ϭ 100% ϫ (V RBC peak Ϫ V RBC con )/V RBC con . Responses where poststimulus V RBC did not return to Ϯ15% of V RBC con were rejected.
Immunoblotting
Immunoblotting was performed on septic and naive control EDL muscle homogenates. Both septic and naive EDL muscles were homogenized in 5 volumes (wt/vol) of ice-cold homogenization buffer (50 mM Tris · HCl, 1.25 mM CaCl 2 , 0.2 mM phenylmethylsulfonyl fluoride, 1 mM EDTA, 10 µg/ml antipain, 10 µg/ml leupeptin, 10 µg/ml pepstatin, 10 µg/ml chymostatin, and 10 µg/ml soybean trypsin inhibitor; pH 7.4). A total of 80 µg of protein for eNOS and iNOS analyses and 100 µg of protein for nNOS analysis were loaded into each well of the mini-gel aparatus (Mini Gel II; Bio-Rad). Separation of NOS isoforms was performed by electrophoresis on a 7.5% SDS-tris-glycine polyacrylamide gel and transferred to a nitrocellulose membrane. The membrane was blocked with 5% wt/vol nonfat milk powder and incubated with mouse primary monoclonal antibodies against eNOS (1:2,500 dilution), iNOS (1:500), and nNOS (1:500) proteins (Transduction Laboratories). Lysates of human endothelial cells, cytokineactivated murine macrophages, and human pituitary cells were used as positive controls, respectively. Membranes were then incubated with a horseradish peroxidase-conjugated anti-mouse secondary antibody (1:1,000; Amersham) for 1 h. Blots were developed by enhanced chemiluminescence (ECL; Amersham) and exposed to X-ray film for 45-60 s. Optical density readings of the blots were obtained and quantified (model GS700; multianalyst version 1.1; Bio-Rad). Control experiments were carried out to ensure that no NOS isozyme cross-reactivity of the employed antibodies occurred.
NOS Activity
NOS enzyme activity in EDL muscle homogenates was measured as described previously by us (38, 39) . In separate experiments, concentration-dependent AG inhibition of nNOS, eNOS, and iNOS isozymes was also determined. nNOS was isolated from rat cerebellar supernatant. Briefly, rat cerebellum were homogenized in 6 volumes (wt/vol) of homogenizing buffer (10 mM HEPES buffer, 0.1 mM EDTA, 1 mM dithiothreitol, 1 mg/ml phenylmethylsulfonyl fluoride, and 0.32 M sucrose; pH 7.4) and centrifuged (100,000 g for 60 min at 4°C in a L5-65B Ultracentrifuge, Beckman Instruments, Mississaga, Ontario, Canada). The cytosolic nNOS from the supernatant was used for subsequent assays. Recombinant bovine eNOS (20 U/ml) and rat iNOS isozymes (250 U/ml) were purchased from Cayman Chemical (Ann Arbor, MI) and diluted to 1:10 (vol/vol) and 1:50, respectively, in homogenization buffer. Inhibition curves were constructed by incubating aliquots (25 µl) of each of the isozymes under control conditions (i.e., all cofactors and substrate provided, with no inhibitors), with increasing concentrations of AG (10 Ϫ10 -10 Ϫ1 M), and with 1 mM N G -nitro-L-arginine methyl ester (to control for background nonspecific radioactivity).
Nitrate and Nitrite Determination
Blood samples from control and septic rats were drawn into heparin sodium vacuum containers and centrifuged for 15 min at 1,000 g. Plasma (10-20 µl) was injected into a purge chamber containing vanadium(III) chloride [to convert
) to NO gas]. NO gas was then carried via inert carrier gas (He) to the NO analyzer (model 270B, Sievers). NO measurement was based on a gas-phase reaction between NO and ozone, producing light detectable by a photomultiplier tube. NO concentrations in plasma samples were determined from a standard curve constructed to sodium nitrate.
Experimental Design: In Vivo Studies
Effect of L-NNA on arteriolar response to ACh. The objective was to establish the presence of the EDRF/NO pathway in the arteriolar response to ACh in control rats. A pretreatment of arteriole with the competitive L-arginine inhibitor (L-NNA) was used for this purpose. The experiment consisted of 1) a 2-min control video recording of blood flow in a capillary, 2) application of a droplet of L-NNA (15 mM) on the feeding arteriole, 3) application (3 min later) of a droplet of ACh (10 mM) on the same arteriolar site, and 4) recording of the ensuing V RBC response in the capillary. In a further experiment, after the 2-min control flow recording in a capillary fed by a different arteriole, a droplet of ACh (10 mM) was applied on this arteriole and the resulting capillary V RBC response recorded. To assess the effect of L-NNA pretreatment, we compared ⌬V RBC values from these two experiments based on V RBC measurements obtained from the video recordings.
Effect of NO donors on arteriolar response to ACh in control rats. To examine whether NO could affect the microvascular response to ACh in skeletal muscle, we pretreated arterioles with either SNP or SNAP (5 mM each; two structurally unrelated NO donors). In practice, blood flow in a capillary was recorded for 2 min and, concurrently, the average V RBC con in this capillary was estimated via online V RBC monitoring. SNP or SNAP was then locally ejected on the feeding arteriole, and the ensuing V RBC response was monitored. As soon as V RBC returned to the V RBC con level (ϳ3-4 min), capillary blood flow was further recorded for 30 s (concurrent on-line monitoring ensured that V RBC remained stable at the V RBC con level). Thirty seconds after the end of this recording (i.e., 4-5 min after SNP/SNAP), ACh (10 mM) was applied on the same arteriolar site and the ensuing V RBC response was recorded. Computed ⌬V RBC was based on off-line V RBC measurements obtained from the 30-s control and the ACh-stimulated response recordings. Arteriolar diameter response to the sequential application of SNAPϩACh was also determined in separate arterioles. Here the delay between the SNAP and ACh applications was not based on on-line monitoring, but rather on the average delay measured in the SNAPϩACh V RBC experiment. The effect of sequential SNPϩACh or SNAPϩACh application was compared with the effect of sequential vehicleϩACh or ACh alone applications, in separate arterioles. Because NO donors themselves cause both dilation and increase in capillary V RBC , the nonspecific effect of dilation and V RBC increase on the subsequent response to ACh was also examined using a different vasodilator (NECA). Arterioles were pretreated with NECA (10 µM), and capillary V RBC was monitored. After V RBC returned to the baseline and the V RBC con stability (30 s) was ensured, ACh was applied (i.e., 4-5 min after NECA) on the same arteriolar site and the resulting V RBC response was recorded. The effect of sequential NECAϩACh application was compared with the effect of ACh alone application on separate arterioles.
Effect of iNOS blockers and NO donors on arteriolar response in septic rats. To determine whether NO is involved in impaired vasodilation in septic skeletal muscle, we aimed to show that 1) the ''selective'' iNOS blockers AG and SMT eliminate the deficit in ACh-stimulated arteriolar response in septic rats, and 2) that NO donors added to AG or SMT re-establish the deficit. A droplet of AG (10 mM) or SMT (5 µM) was applied on the septic arteriole; 5 min later, ACh (10 mM) was applied on the same site and the capillary V RBC response was recorded. A droplet of the mixture (10 mM AG ϩ 5 mM SNP, 10 mM AG ϩ 5 mM SNAP, or 5 mM SMT ϩ 5 mM SNAP) was then applied on separate septic arterioles and the capillary V RBC was monitored. When V RBC returned to the baseline and V RBC con stability was ensured, ACh (10 mM) was applied (i.e., 4-5 min after the mixture) on the same arteriolar site and the V RBC response was recorded. Arteriolar diameter responses to AGϩACh and to (AGϩSNAP)ϩACh were also obtained. Responses to AGϩACh, SMTϩACh, (AGϩSNP)ϩACh, (AGϩSNAP)ϩACh, or (SMTϩSNAP)ϩACh were compared with responses to vehicleϩACh or to ACh alone applied on separate septic arterioles. In this study we also tested whether the 5-min pretreatment with AG or SMT affected the V RBC response to ACh in control rats. Responses to AGϩACh or to SMTϩACh were compared with responses to ACh alone measured in separate control arterioles.
Effect of NO on endothelium-independent vasorelaxation in control and septic rats. NO stimulates guanylate cyclase to produce smooth muscle relaxation. The overproduction of NO in sepsis could desensitize guanylate cyclase and indirectly result in a deficit in ACh-stimulated vasodilation. The objectives were to test 1) the effect of NO donor on the endotheliumindependent arteriolar dilation (caused by SNAP) in control rats, 2) the presence of endothelium-independent dilation in septic rats, and 3) the effect of AG on a possible enhancement of endothelium-independent dilation in septic rats. Control arterioles were locally stimulated with SNAP (5 mM); when capillary V RBC returned to the baseline and V RBC con stability ensured, SNAP (5 mM) was applied again (i.e., 4-5 min after the previous SNAP) on the same site. V RBC responses to sequential SNAPϩSNAP and responses to SNAP alone were compared. Septic arterioles were then locally stimulated with SNAP (5 mM) and capillary V RBC responses were recorded. Finally, separate septic arterioles were locally pretreated with AG (10 mM); after 5 min they were stimulated with SNAP (5 mM). For septic arterioles, we compared capillary V RBC responses between SNAP and AGϩSNAP groups; we also compared responses to SNAP between control and septic arterioles.
Experimental Design: In Vitro Studies
Immunoblotting of NOS isozymes in EDL muscles of control and septic rats. It is possible that the deficit in vasodilation to ACh in sepsis is due to an increased production of NO via iNOS or due to downregulation of the eNOS protein itself (22, 24, 53) . Assessment of the relative amount of the NOS isozymes protein levels in control and septic muscles was carried out to address these possibilities.
cNOS and iNOS enzyme activities. To complement the immunoblotting study, we determined the cNOS (i.e., nNOS and eNOS) and iNOS enzyme activities of control and septic EDL muscles. To complement the in vivo studies, we also tested for the effect of the ''selective'' iNOS blockers AG (100 µM) and SMT (30 nM). Enzyme activities with AG or SMT treatment were compared with those with potassium phosphate buffer. On the basis of our previous work (28) indicating that drugs in the pipette were diluted ϳ100ϫ before reaching the arteriolar wall, these blocker concentrations approximated the effective concentrations of our in vivo experiments.
Data Analysis
For each rat, the effect of a particular stimulus was analyzed in one to three arterioles; data from these arterioles were averaged. Data in this study are presented as means Ϯ SE, based on the number of rats (n). For both control and septic groups, ANOVA was performed among D con in different experiments to ensure that control and septic rats came from the same populations. Data from in vivo experiments were analyzed using Student's t-test with a Bonferroni correction for multiple comparisons, unless stated otherwise. Systemic parameter measurements (Table 1) , immunoblot optical density, and enzyme activity data were compared with the Student's t-test. P values Ͻ0.05 were considered significant. All tests were calculated with Systat 6.01 statistical software.
RESULTS
Baseline measurements of systemic parameters in control and septic rats under the conditions of pentobarbital anesthesia and ventilation are shown in Table 1 (note that not all parameters could be measured in all control and septic animals). Sepsis induced 2.6-and 2.0-fold increases in plasma lactate and NO x Ϫ levels, respectively. Despite fluid resuscitation, septic rats had a slightly lower arterial pressure than control rats; however, both groups were normotensive. Data of systemic parameters were consistent with our earlier studies (18, 46) of this model of sepsis. The baseline diameter of terminal arterioles was also slightly reduced in septic rats (Table 1) . This reduction appears to contradict the reported no change (2) or increase in diameter of terminal arterioles in sepsis (1, 25) . The discrepancy could be due to the inherent technical difficulty associated with arteriolar diameter measurement in the model. Because of epi-illumination of the EDL muscle surface, deeper arterioles or proximal segments of arterioles (i.e., Ͼ200 µm upstream from the last bifurcation) were not accessible for measurement. It is possible that the selection process excluded deeper or proximal vessels that could be dilated in sepsis. Thus conclusions based on arteriolar diameter measurement in the present study are limited to the population of arterioles examined. Postmortem examination of both the lungs and abdominal cavity revealed necrotic areas of the lungs, necrotic cecum, and purulent peritoneal fluid in septic rats. In contrast, control rats had normal lungs and abdominal peritoneal cavity. The mortality rate associated with the CLP procedure was 23%.
Response to ACh in control rats. Similar to our previous study (46) , ACh caused peak increases of 100-120% and 25-30% in capillary V RBC and arteriolar diameter, respectively. Responses occurred within sev- Values are means Ϯ SE. Numbers in parentheses indicate number of rats. NS, nonsignificant difference between groups, P Ͼ 0.05. (N.B. from all rats prepared for intravital microscopic examination of skeletal muscle only a subset was used for arteriolar diameter measurement.) eral seconds after the application of ACh and lasted ϳ2-3 min. Pretreatment with L-NNA resulted in a significant 67% reduction in the V RBC response to ACh [116 Ϯ 17% increase after ACh versus 39 Ϯ 6% increase after L-NNAϩACh; V RBC con : 140 Ϯ 7 µm/s (n ϭ 14) and 158 Ϯ 9 µm/s (n ϭ 11), respectively], indicating the presence of the EDRF/NO pathway in the arteriolar response to ACh. The residual response to ACh (i.e., 39% increase) could have reflected the fact that the concentration of L-NNA was not sufficiently high to completely block the response to ACh, or that an alternative pathway (e.g., endothelium-derived hyperpolarizing factor, EDHF) was involved in the response. L-NNA itself had no significant effect on V RBC . Arterioles treated with the vehicle PBS did not affect V RBC (12 Ϯ 20% change, n ϭ 5) or the V RBC response to ACh (95 Ϯ 25%, n ϭ 5).
The effect of NO donors on ACh-stimulated V RBC increase in control rats is shown in Fig. 1 . SNP and SNAP pretreatment caused significant reductions (63 and 59%, respectively) in the response to ACh, respectively, whereas pretreatment with the saline vehicle had no effect. Arteriolar diameter measurements confirmed these results. Diameter increases after ACh alone (30 Ϯ 3%, D con ϭ 8.6 Ϯ 0.6 µm, n ϭ 11) and after salineϩACh (26 Ϯ 4%, D con ϭ 8.3 Ϯ 0.6 µm, n ϭ 6) did not differ, whereas the increase after SNAPϩACh (10 Ϯ 3%, D con ϭ 9.1 Ϯ 0.5 µm, n ϭ 9) was significantly smaller. SNP or SNAP pretreatment caused a temporary ϳ100% increase in V RBC that lasted 3-4 min. Arteriolar pretreatment with NECA had no effect on the V RBC response to ACh; we measured 116 Ϯ 17% (n ϭ 14) and 123 Ϯ 18% (n ϭ 7) increases after ACh alone and after NECAϩACh applications, respectively.
Response to ACh in septic rats. Sepsis caused a significant attenuation in the ACh-stimulated increase in capillary V RBC [36 Ϯ 6% (Fig. 2) vs. 116 Ϯ 17% in controls ( Fig. 1)] and arteriolar diameter (8 Ϯ 2% vs.
30 Ϯ 3% in controls). Pretreatment with AG or SMT eliminated this deficit (Fig. 2) . The same elimination was seen in the diameter data: AGϩACh application on septic arterioles caused a 24 Ϯ 3% dilation (D con ϭ 7.5 Ϯ 0.5 µm, n ϭ 12), which was not different from the dilation to ACh seen in control rats. Pretreatment of septic arterioles with saline (i.e., the vehicle of AG and SMT) had no effect on the deficit (i.e., ACh induced only a 32 Ϯ 10% increase in V RBC , n ϭ 5). SNP or SNAPϩAG restored the deficit (Fig. 2) . SNAPϩSMT also restored the deficit (Fig. 2) . Diameter data confirmed this effect, because (AGϩSNAP)ϩACh caused only a 6 Ϯ 2% increase (D con ϭ 7.7 Ϯ 0.4 µm, n ϭ 12). In control rats, pretreatment with AG or with SMT did not affect the V RBC response to ACh; responses to AGϩACh (92 Ϯ 18%, n ϭ 8) and to SMTϩACh (117 Ϯ 20%, nϭ 5) did not differ from the response to ACh alone (Fig. 1) .
Response to an endothelium-independent stimulus. Figure 3 shows that, in terms of the ⌬V RBC response to SNAP, there was no difference in the endotheliumindependent response between control and septic rats. In control rats, pretreatment with the NO donor SNAP did not affect the response to SNAP (i.e., SNAPϩSNAP data in Fig. 3) . In septic rats, pretreatment with AG did not affect the response to SNAP either (AGϩSNAP data in Fig. 3) .
Western blots and enzyme activity. Figure 4 (left and middle immunoblots) shows that sepsis had no effect on the level of iNOS protein (120 kDa) or the level of eNOS protein (135 kDa) in the EDL muscle at the 24-h time point. Figure 5 shows that sepsis significantly elevated the cNOS (i.e., calcium-dependent eNOSϩnNOS) activity, whereas it did not affect the iNOS (i.e., calciumdependent) activity at 24 h. Protein concentrations in the control (15.9 Ϯ 1.9 mg/ml) and septic (14.7 Ϯ 1.6 mg/ml) homogenates were similar. Figure 6 shows that, in septic rats, AG (100 µM) and SMT (30 nM) reduced the cNOS activity toward the level seen in control rats (Fig. 5, left open bar) .
Involvement of nNOS. The lack of elevation in the iNOS protein and enzyme activity levels at the 24-h time point of sepsis was unexpected. Because the increased cNOS (i.e., eNOSϩnNOS) activity in sepsis was reduced by AG to the cNOS level observed in control rats, we pursued the possibility that sepsis elevated nNOS rather than iNOS. Figure 4 (right immunoblots and densitometry readings) demonstrates that the nNOS protein expression in EDL muscles from septic rats was indeed significantly higher than in control rats. The upper band in the septic lane (165 kDa; seen consistently only in nNOS blots from septic muscles) was apparently of a slightly lower molecular mass than the pituitary lysate nNOS protein. This was likely due to the presence of the truncated, splice-variant skeletal muscle µNOS, which still retains the epitope to the antibody (9) . Alternatively, the upper band (and the lower band seen in both control and septic lanes) may represent denaturation products of the nNOS in the preparation of the protein sample. Densitometry was performed using both upper and Fig. 3 . Effect of an endothelium-independent stimulus (SNAP) on capillary V RBC in control and septic rats. Open bars, effect of a droplet of SNAP (5 mM) applied on arteriole in control rats, with and without 4-5 min arteriolar pretreatment with SNAP (5 mM). Solid bars, effect of SNAP (5 mM) applied on arteriole and of SNAP after 5-min arteriolar pretreatment with AG (10 mM) in septic rats. V RBC baselines (from left to right, 133 Ϯ 14, 147 Ϯ 12, 133 Ϯ 12, and 143 Ϯ 15 µm/s) were comparable. Numbers in parentheses denote number of animals. Fig. 4 . Examples of immunoblots of control and septic rat EDL muscle homogenates (A), and densitometry readings (B), using antiinducible nitric oxide synthase (iNOS), antiendothelial NOS (eNOS), anti-neuronal NOS (nNOS) monoclonal antibodies, and cytokineinduced murine macrophages (Mac), human endothelial cell (EC) lysate, and human pituitary cell lysate as positive controls, respectively. Molecular mass of iNOS, eNOS, and nNOS (upper band in septic lane) proteins was 120, 135, and 165 kDa, respectively. Densitometry readings for eNOS and nNOS were normalized to average reading in the control lane. Numbers in parentheses denote number of animals. *Significant difference between control and septic groups. Fig. 5 . In vitro constitutive NOS (cNOS) (i.e., eNOSϩnNOS) and iNOS enzyme activities measured in control and septic EDL muscle homogenates. Numbers in parentheses denote number of animals. *Significant difference between cNOS activities in control and septic muscles. lower bands; it consistently exhibited an increased nNOS-positive protein in the septic lanes compared with controls lanes.
To determine whether functional inhibition of nNOS affects the ACh-stimulated vasodilation deficit in septic rats, we used the putative nNOS inhibitor 7-NI (17) in our in vivo experiment. First, we used a cerebellum homogenate from rat (a source of high nNOS content; 10) to confirm that 7-NI (1 µM) is capable of blocking nNOS enzyme activity (data not shown). Next, arterioles in septic rats were pretreated locally for 5 min with 7-NI (100 µM), and the V RBC response to ACh was examined. Figure 7 shows that 7-NI significantly increased this response in septic rats. Finally, concentration-dependent inhibition of nNOS, eNOS, and iNOS isozyme activities by AG was determined in vitro. On the basis of inhibition curves done in quadruplicate for each isozyme (Fig. 8) , IC 50 values for AG were calculated (Fig. 8 ) using a linear regression of the Hill plot (i.e., intercept values). These IC 50 values indicate that all of the NOS isozymes are capable of inhibition by AG.
DISCUSSION
The key findings of the present study were 1) the deficit in ACh-stimulated arteriolar dilation in sepsis was ''immediately'' eliminated by AG and SMT, but restored by NO donors; 2) in the EDL muscle, sepsis was not associated with an induction of iNOS or a change in eNOS, but rather there was an increase in nNOS protein level; and 3) sepsis elevated calciumdependent (eNOSϩnNOS) but not calcium-independent iNOS enzyme activity. These results are consistent with the hypothesis that NO inhibits arteriolar dilation to ACh but indicate that nNOS rather than iNOS could be the source of increased NO in skeletal muscle during sepsis.
Effect of NO donors on arteriolar response to ACh in control rats. The rationale for using NO donors in control rats was to establish that exogenous NO per se can affect the vascular response to ACh. Although the response can be mediated by one of, or a combination of, at least three pathways (i.e., EDRF/NO, EDHF, and prostaglandins), the major component of this response in arterioles of the present EDL muscle model appeared to be mediated by the EDRF/NO pathway. L-NNA caused a substantial attenuation (67%) of the V RBC response to ACh. A similar contribution of the EDRF/NO pathway was reported for the response in terminal arterioles of the rat cremaster muscle (47) .
The present data ( Fig. 1) demonstrate that exogenous NO can inhibit the vascular response to ACh, but they do not explain the exact mechanism of this inhibition. An indirect inhibitory effect of NO on muscarinic receptor/G protein function via activation of guanylyl cyclase is possible (29) , because an NO donor has been shown to modulate the bradykinin (BK)-signaling pathway in endothelial cells in vitro by selectively inhibit- Fig. 6 . In vitro cNOS and iNOS activities in septic rat EDL muscle homogenates in the presence or absence (control bars on left) of iNOS inhibitors AG (100 µM) or SMT (30 nM). AG and SMT reduced cNOS activity to level seen in control rats (Fig. 5, left) . Numbers in parentheses denote number of animals. *Significant change from cNOS activity in control (untreated) homogenates. Fig. 7 . Effect of arteriolar stimulation with ACh on capillary V RBC in septic rats. Left, response to ACh (10 mM) alone. Right, response to ACh applied 5 min after arteriolar pretreatment with nNOS inhibitor 7-nitroindazole (7-NI) (100 µM). V RBC baselines (158 Ϯ 13 and 136 Ϯ 10 µm/s, respectively) were comparable. Numbers in parentheses denote number of animals. *Significant increase based on one-tail t-test. ing G proteins of the G i and G q family (29) . Alternatively, it has been shown in vitro that NO can directly inhibit NOS activity, in particular eNOS (3, 35) , likely through interaction with the heme moiety of NOS (50) . There is also evidence that NO can participate in the regulation of the EDRF/NO pathway in vivo. Cohen et al. (6) showed that infusion of an NO donor into rabbit hindquarters attenuated the endothelium-dependent (agents: ACh, BK), but not the endothelium-independent, vasodilator response (agent: SNAP). Our data confirmed and extended this observation by determining the effect of NO donors at the level of a single microvessel (Figs. 1 and 3) . Furthermore, we have demonstrated that this effect was not due to a nonspecific vasodilator effect of the donor since NECA (another vasodilator) failed to attenuate the V RBC response to ACh.
Our protocol of sequential application of NO donors and ACh did not permit an assessment of the maximal inhibition by NO donors. Assuming that the amount of NO given off by the donors at the arteriole dictated the degree of dilation and V RBC increase, the maximum effect of donors would have occurred several seconds after their application, at the peak of dilation. The necessity of waiting for the diameter and V RBC to return to baseline might have resulted in a smaller amount of NO donors (and hence, NO) at the site of the arteriole at the time of ACh application. In terms of the vascular response to ACh, the effect of the smaller amount of NO at the arteriole in control rats could have mimicked the effect of sepsis. This is because 1) the immediate pre-ACh arteriolar diameter was similar to that in septic rats, and 2) the donor-mediated attenuation in response to ACh was similar to the attenuation seen in septic rats (compare SNPϩACh or SNAPϩACh data in Fig. 1 to ACh data in Fig. 2) . Hence, the NO levels in SNP/SNAP-treated controls were likely similar to those in septic EDL muscles, resulting in similar attenuation of the ACh-stimulated vasodilation.
Effect of sepsis on arteriolar response to ACh. The sepsis-induced deficit in dilation (i.e., an 8% instead of 30% diameter increase) of the present study agrees with the reported attenuation of response to ACh in several models of sepsis (1, 25, 34, 46, 48) . The present deficit was not due to the limited ability of the arteriole to relax, because there were several stimuli that yielded responses well above the level of deficit (i.e., see responses to AGϩACh, SMTϩACh, and SNAP in Figs. 2  and 3 ). Our data (Fig. 3 , SNAP in sepsis) agree with reports of no attenuation of endothelium-independent dilation (25, 34, 48) and suggest that the deficit was mediated through the loss of endothelium-dependent dilation.
The attenuated responsiveness to ACh could be due to a sepsis-induced change in the muscarinic receptor and/or G protein function. Indeed, sepsis has been shown to alter the expression of G protein regulator proteins (33) and of specific G protein ␣-subunits (51). However, the immediate and complete restoration of the dilation to ACh, following treatment with AG or SMT (Fig. 2) , indicated that an NO-dependent mechanism was more likely responsible for the vasodilation deficit. This deficit was unlikely to be explained by a loss of substrate (L-arginine) for eNOS (49) or insufficient production of the cofactor tetrahydrobiopterin (13) in endothelial cells, because both the L-arginine transporter and GTP cyclohydrolase I, respectively, are upregulated in vitro following treatment with lipopolysaccharides (LPS). Endotoxemia has been reported to reduce both basal eNOS activity (30) , ACh-stimulated eNOS activity, and ACh-stimulated NO production in blood vessels (31) . Cytokines and/or endotoxin has been shown to downregulate eNOS mRNA (24, 52) , whereas the CLP model of sepsis reduced the eNOS protein level in aortic endothelial cells (53) . However, downregulation of eNOS in skeletal muscle was an unlikely mechanism of the deficit in the present study, because the level of eNOS protein was not altered by sepsis whereas the cNOS (eNOSϩnNOS) enzyme activity was substantially increased. Furthermore, the 5-min period required by AG or SMT to eliminate the deficit (Fig. 2) would seem too short for de novo synthesis of eNOS.
It has been proposed that the continuous production of NO via iNOS during endotoxemia is responsible for the decreased sensitivity to ACh-mediated vasodilation (38, 46) . Endotoxemia is known to be associated with elevated iNOS mRNA, protein, and enzyme activity levels in many tissues (8, 21, 38, 43) . At first glance, the data in Fig. 1 appear to agree with this proposal, because experiments in control rats indicated that NO could attenuate the arteriolar response to ACh. Furthermore, the data in Fig. 2 [(AGϩSNP)ϩACh, (AGϩSNAP) ϩACh, and (SMTϩSNAP)ϩACh groups] confirmed that NO could cause a comparable attenuation in septic rats, and that the ''selective'' iNOS inhibitors AG and SMT eliminated the deficit in ACh-stimulated response. However, the lack of iNOS protein expression and activity in the septic EDL muscle (Figs. 4 and 5) contradict the literature reports from other organs (8, 21, 38) . If increased NO were involved in the observed vasodilation deficit, but iNOS was not present, where did the increased NO come from?
The endotoxin-induced increase in iNOS expression in skeletal muscle (8, 43) has been shown to be much more transient than that observed in large blood vessels following LPS or CLP treatment (38, 39) . In mouse skeletal muscle, LPS-stimulated iNOS mRNA expression peaked around 4 h and then subsided at 8 h, whereas the iNOS protein level followed a similar time course resulting in a dramatic reduction by 12 h (43). In the rat diaphragm, iNOS protein and enzyme activity peaked 12 h after endotoxin injection and disappeared by 24 h (8). These earlier findings agree with the present lack of iNOS protein and enzyme activity found 24 h after the CLP procedure. However, the present findings do not exclude a possible, yet undiscovered, earlier effect of elevated iNOS level (e.g., at 12 h) on the vasodilation deficit seen at 24 h.
Contrary to the findings (38, 39) in conduit vessels in CLP rats, cNOS activity in our septic EDL muscle doubled compared with controls (Fig. 5) . Recently, it has been shown (8) in septic rat skeletal muscles that cNOS activity rises substantially within 12 h after endotoxin injection and remains elevated for 24 h. The increase of cNOS activity has been attributed to an induction of nNOS [or the skeletal muscle splicevariant of nNOS (µNOS)], or to a decrease in the tissue level of an endogenous protein inhibitor of nNOS (11) . The present results from septic rats confirmed these findings in terms of significant increases in cNOS activity and in protein expression of nNOS in the EDL muscle. Thus an NO-mediated functional inhibition of ACh-stimulated response could involve nNOS rather than iNOS upregulation in septic skeletal muscle. This proposal is consistent with the current observation that the putative nNOS inhibitor (7-NI) improved the V RBC response to ACh in sepsis (Fig. 7) .
In endotoxin-injected rats, the increase in nNOS protein in rat skeletal muscle has previously been shown (8) to be localized in the subsarcolemmal space. On the basis of this report, the present study suggests that, in terms of NOS protein profile at 24-h post-CLP (Fig. 4) , the effect of sepsis was precipitated in the parenchymal tissue rather than in the vasculature. Thus sepsis-induced changes in the parenchyma (i.e., increased NO production) appeared to affect the vascular behavior (i.e., arteriolar response to ACh). Therefore, we propose that studies addressing the effect of sepsis in different segments of the vascular tree should take into account the alteration of the parenchymal cellular milieu.
Effect of ''selective'' iNOS inhibition with AG and SMT. The lack of detectable change in iNOS protein in septic EDL muscle raises the question of how the ''selective'' iNOS inhibitors AG and SMT restored the ACh-mediated vasodilation in septic arterioles. Because 1) AG and SMT did not attenuate the V RBC response to ACh (i.e., indirect measure of eNOS activity) in control rats, 2) eNOS protein expression was not increased in sepsis (Fig. 4) , and 3) iNOS was not detectable, it is possible that the inhibitors affected nNOS rather than iNOS in septic skeletal muscle. Thus the nNOS likely produced sufficient NO to attenuate the ACh-mediated vasodilation, which would otherwise have been attributed to the elevated iNOS activity in sepsis. This is corroborated by the current observations that 1) AG did not significantly reduce cNOS activities (i.e., the eNOS plus nNOS activities) in control muscle, 2) AG restored the high cNOS activity in septic muscle to the level seen in control tissues (Fig. 6) , and 3) AG inhibited both eNOS and nNOS at higher concentrations (Fig. 8) . Although both AG and SMT have been previously shown to be 30-40 times more selective for iNOS than the cNOS isozymes (12, 27, 43) , the present data agree with the reports that AG and SMT are capable of inhibiting both isozymes (15, 20, 41) . Thus caution must be exercised when these ''selective'' inhibitors are used in situations that may involve both nNOS and iNOS isozymes.
In conclusion, the present study demonstrated for the first time that NO donors can attenuate the microvascular response to ACh in both control and septic rats and that, surprisingly, the possible increased endogenous NO may come from upregulated nNOS and not iNOS protein at 24 h after the CLP procedure. The study is consistent with the hypothesis that increased production of NO, rather than downregulation of eNOS, is responsible for the deficit in vasodilation to ACh observed in the microvasculature of septic rat skeletal muscle.
